NCT05215132 Investigational MRI Clinical Software and Hardware
| NCT ID | NCT05215132 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Northwestern University |
| Condition | Image, Body |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2019-12-19 |
| Primary Completion | 2028-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 2,000 participants in total. It began in 2019-12-19 with a primary completion date of 2028-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients and healthy volunteers will be scanned in order to test new sequences.
Eligibility Criteria
Inclusion Criteria: * • At least 18 years of age * Able to complete the MR safety questionnaire. * Able to comprehend and provide informed consent in English. * When contrast is being administered: healthy volunteers with a GFR≥60 ml/min * When contrast is being administered: patients with a GFR ≥30 ml/min Exclusion Criteria: * • When contrast is being administered: subjects with a GFR \< 30 ml/min * When contrast is being administered: subjects with acute kidney injury * When contrast is administered, allergy to gadolinium-containing contrast media * Contraindication to MRI (implanted device, claustrophobia, dyspnea precluding the ability to follow breath-hold instructions) * Adults unable to consent * Individuals who are not yet adults * Pregnant or breastfeeding women * Prisoners
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05215132 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Image, Body. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT05215132 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT05215132 currently recruiting?
Yes, NCT05215132 is actively recruiting participants. Contact the research team at emily.powell@northwestern.edu for enrollment information.
Where is the NCT05215132 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT05215132 clinical trial?
NCT05215132 is sponsored by Northwestern University. The trial plans to enroll 2,000 participants.